FH enhances the therapeutic effect of PD-1 inhibitors on colorectal cancer by inhibiting the expression of PCSK9.
We performed FH knockdown in colorectal cancer cells along with RNA sequencing. The expression profiling showed PCSK9 as a potential FH target and the conclusions were also verified in clinical samples. Overall design: RNA sequencing in SW620 cell lines with si-Control or si-FH